Volume 14 Issue 2
Mar.  2023
Turn off MathJax
Article Contents
Gao Hongjun, Qiu Minhua, Chen Jibing. Research progress on islet protection and functional maintenance[J]. ORGAN TRANSPLANTATION, 2023, 14(2): 207-212. doi: 10.3969/j.issn.1674-7445.2023.02.005
Citation: Gao Hongjun, Qiu Minhua, Chen Jibing. Research progress on islet protection and functional maintenance[J]. ORGAN TRANSPLANTATION, 2023, 14(2): 207-212. doi: 10.3969/j.issn.1674-7445.2023.02.005

Research progress on islet protection and functional maintenance

doi: 10.3969/j.issn.1674-7445.2023.02.005
More Information
  • Corresponding author: Gao Hongjun, Email: gao4056@163.com
  • Received Date: 2022-12-09
    Available Online: 2023-03-15
  • Publish Date: 2023-03-15
  • Islet transplantation is a promising treatment of diabetes mellitus and its complications. Nevertheless, dysfunction post-transplantation, rejection and shortage of donors are the bottleneck issues in the field of islet transplantation. Optimizing the preservation method of pancreas plays a positive role in obtaining a sufficient quantity of effective islets and maintaining their functions. During the culture stage, anti-rejection and anti-apoptosis treatment of islets, including mesenchymal stem cell (MSC), MSC-derived exosomes, anti-apoptosis drugs and gene modification, may become major approaches for islet protection and functional maintenance in clinical islet transplantation. Use of anti-instant blood-mediated inflammatory reaction (IBMIR) drugs after islet transplantation also plays a critical role in protecting islet function. In this article, the whole process from islet preparation to islet transplantation was illustrated, and relevant strategies of islet protection and functional maintenance were reviewed, aiming to provide reference for improving the quality of donors to compensate for the shortage of absolute quantity of donors and elevating the efficiency of islet transplantation.

     

  • loading
  • [1]
    CENGIZ E, DANNE T, AHMAD T, et al. ISPAD clinical practice consensus guidelines 2022: insulin treatment in children and adolescents with diabetes[J]. Pediatr Diabetes, 2022, 23(8): 1277-1296. DOI: 10.1111/pedi.13442.
    [2]
    王宇琴, 朱永星, 冉隆梅, 等. 整合医学模式下2型糖尿病个性化干预的临床效果研究[J]. 实用医学杂志, 2022, 38(18): 2346-2351. DOI: 10.3969/j.issn.1006-5725.2022.18.017.

    WANG YQ, ZHU YX, RAN LM, et al. Clinical effect of personalized intervention for patients with type 2 diabetes with holistic integrative medicine[J]. J Pract Med, 2022, 38(18): 2346-2351. DOI: 10.3969/j.issn.1006-5725.2022.18.017.
    [3]
    张汀滢, 刘桃丽, 胡建国, 等. 中医禁食疗法对超重/肥胖2型糖尿病患者的临床疗效[J]. 中山大学学报(医学科学版), 2022, 43(4): 613-620. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2022.0412.

    ZHANG TY, LIU TL, HU JG, et al. Clinical effects of Chinese medicine fasting therapy in overweight/obese type 2 diabetes patients[J]. J Sun Yat-sen Univ (Med Sci), 2022, 43(4): 613-620. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2022.0412.
    [4]
    傅红兴. 胰岛移植概况[J/CD]. 中华细胞与干细胞杂志(电子版), 2022, 12(4): 0-I. DOI: 10.3877/cma.j.issn.2095-1221.2022.04.010.

    FU HX. Overview of islet transplantation[J/CD]. Chin J Cell Stem Cell (Electr Edit), 2022, 12(4): 0-I. DOI: 10.3877/cma.j.issn.2095-1221.2022.04.010.
    [5]
    KUO CH, LI HY. Pancreatic islet transplantation in type 1 diabetes: current state and future perspectives[J]. J Diabetes Investig, 2023, 14(2): 183-185. DOI: 10.1111/jdi.13942.
    [6]
    BERNEY T, WASSMER CH, LEBRETON F, et al. From islet of Langerhans transplantation to the bioartificial pancreas[J]. Presse Med, 2022, 51(4): 104139. DOI: 10.1016/j.lpm.2022.104139.
    [7]
    DANOBEITIA JS, CHLEBECK PJ, SHOKOLENKO I, et al. Novel fusion protein targeting mitochondrial DNA improves pancreatic islet functional potency and islet transplantation outcomes[J]. Cell Transplant, 2017, 26(11): 1742-1754. DOI: 10.1177/0963689717727542.
    [8]
    NISHIME K, MIYAGI-SHIOHIRA C, KUWAE K, et al. Preservation of pancreas in the University of Wisconsin solution supplemented with AP39 reduces reactive oxygen species production and improves islet graft function[J]. Am J Transplant, 2021, 21(8): 2698-2708. DOI: 10.1111/ajt.16401.
    [9]
    LEMAIRE F, SIGRIST S, DELPY E, et al. Beneficial effects of the novel marine oxygen carrier M101 during cold preservation of rat and human pancreas[J]. J Cell Mol Med, 2019, 23(12): 8025-8034. DOI: 10.1111/jcmm.14666.
    [10]
    SAKAI-YONAHA M, MIYAGI-SHIOHIRA C, KUWAE K, et al. Pancreas preservation in modified histidine-lactobionate solution is superior to that in University of Wisconsin solution for porcine islet isolation[J]. Transplantation, 2022, 106(9): 1770-1776. DOI: 10.1097/TP.0000000000003636.
    [11]
    KUWAE K, MIYAGI-SHIOHIRA C, HAMADA E, et al. Excellent islet yields after 18-h porcine pancreas preservation by ductal injection, pancreas preservation with MK solution, bottle purification, and islet purification using iodixanol with UW solution and iodixanol with MK solution[J]. J Clin Med, 2019, 8(10): 1561. DOI: 10.3390/jcm8101561.
    [12]
    OTSUKA R, MIYAGI-SHIOHIRA C, KUWAE K, et al. Pancreas preservation with a neutrophil elastase inhibitor, alvelestat, contributes to improvement of porcine islet isolation and transplantation[J]. J Clin Med, 2022, 11(15): 4290. DOI: 10.3390/jcm11154290.
    [13]
    NOGUCHI H, MIYAGI-SHIOHIRA C, NAKASHIMA Y, et al. A novel preservation solution containing a JNK inhibitory peptide efficiently improves islet yield for porcine islet isolation[J]. Transplantation, 2019, 103(2): 344-352. DOI: 10.1097/TP.0000000000002555.
    [14]
    WASSMER CH, PERRIER Q, COMBESCURE C, et al. Impact of ischemia time on islet isolation success and posttransplantation outcomes: a retrospective study of 452 pancreas isolations[J]. Am J Transplant, 2021, 21(4): 1493-1502. DOI: 10.1111/ajt.16320.
    [15]
    DOPPENBERG JB, LEEMKUIL M, ENGELSE MA, et al. Hypothermic oxygenated machine perfusion of the human pancreas for clinical islet isolation: a prospective feasibility study[J]. Transpl Int, 2021, 34(8): 1397-1407. DOI: 10.1111/tri.13927.
    [16]
    KESHTKAR S, KAVIANI M, JABBARPOUR Z, et al. Hypoxia-preconditioned Wharton's Jelly-derived mesenchymal stem cells mitigate stress-induced apoptosis and ameliorate human islet survival and function in direct contact coculture system[J]. Stem Cells Int, 2020: 8857457. DOI: 10.1155/2020/8857457.
    [17]
    GOU W, WANG J, SONG L, et al. Alpha-1 antitrypsin suppresses macrophage activation and promotes islet graft survival after intrahepatic islet transplantation[J]. Am J Transplant, 2021, 21(5): 1713-1724. DOI: 10.1111/ajt.16342.
    [18]
    KESHTKAR S, KAVIANI M, SARVESTANI FS, et al. Exosomes derived from human mesenchymal stem cells preserve mouse islet survival and insulin secretion function[J]. EXCLI J, 2020, 19: 1064-1080. DOI: 10.17179/excli2020-2451.
    [19]
    CHEN J, CHEN J, CHENG Y, et al. Mesenchymal stem cell-derived exosomes protect beta cells against hypoxia-induced apoptosis via miR-21 by alleviating ER stress and inhibiting p38 MAPK phosphorylation[J]. Stem Cell Res Ther, 2020, 11(1): 97. DOI: 10.1186/s13287-020-01610-0.
    [20]
    WEN D, PENG Y, LIU D, et al. Mesenchymal stem cell and derived exosome as small RNA carrier and immunomodulator to improve islet transplantation[J]. J Control Release, 2016, 238: 166-175. DOI: 10.1016/j.jconrel.2016.07.044.
    [21]
    MASUDA Y, VAZIRI ND, LI S, et al. The effect of Nrf2 pathway activation on human pancreatic islet cells[J]. PLoS One, 2015, 10(6): e0131012. DOI: 10.1371/journal.pone.0131012.
    [22]
    MENGER MM, NALBACH L, ROMA LP, et al. Erythropoietin exposure of isolated pancreatic islets accelerates their revascularization after transplantation[J]. Acta Diabetol, 2021, 58(12): 1637-1647. DOI: 10.1007/s00592-021-01760-4.
    [23]
    PRUD'HOMME GJ, GLINKA Y, HASILO C, et al. GABA protects human islet cells against the deleterious effects of immunosuppressive drugs and exerts immunoinhibitory effects alone[J]. Transplantation, 2013, 96(7): 616-623. DOI: 10.1097/TP.0b013e31829c24be.
    [24]
    YAMANE K, ANAZAWA T, TADA S, et al. Mitomycin C treatment improves pancreatic islet graft longevity in intraportal islet transplantation by suppressing proinflammatory response[J]. Sci Rep, 2020, 10(1): 12086. DOI: 10.1038/s41598-020-69009-8.
    [25]
    STAELS W, VERDONCK Y, HEREMANS Y, et al. Vegf-A mRNA transfection as a novel approach to improve mouse and human islet graft revascularisation[J]. Diabetologia, 2018, 61(8): 1804-1810. DOI: 10.1007/s00125-018-4646-7.
    [26]
    HU M, HAWTHORNE WJ, YI S, et al. Cellular immune responses in islet xenograft rejection[J]. Front Immunol, 2022, 13: 893985. DOI: 10.3389/fimmu.2022.893985.
    [27]
    MOU L, SHI G, COOPER DKC, et al. Current topics of relevance to the xenotransplantation of free pig islets[J]. Front Immunol, 2022, 13: 854883. DOI: 10.3389/fimmu.2022.854883.
    [28]
    HAWTHORNE WJ, SALVARIS EJ, CHEW YV, et al. Xenotransplantation of genetically modified neonatal pig islets cures diabetes in baboons[J]. Front Immunol, 2022, 13: 898948. DOI: 10.3389/fimmu.2022.898948.
    [29]
    YAO M, DOMOGATSKAYA A, ÅGREN N, et al. Cibinetide protects isolated human islets in a stressful environment and improves engraftment in the perspective of intra portal islet transplantation[J]. Cell Transplant, 2021, 30: 9636897211039739. DOI: 10.1177/09636897211039739.
    [30]
    LEE CA, DHAWAN A, SMITH RA, et al. Instant blood-mediated inflammatory reaction in hepatocyte transplantation: current status and future perspectives[J]. Cell Transplant, 2016, 25(7): 1227-1236. DOI: 10.3727/096368916X691286.
    [31]
    YAN LL, YE LP, CHEN YH, et al. The influence of microenvironment on survival of intraportal transplanted islets[J]. Front Immunol, 2022, 13: 849580. DOI: 10.3389/fimmu.2022.849580.
    [32]
    LIUWANTARA D, CHEW YV, FAVALORO EJ, et al. Characterizing the mechanistic pathways of the instant blood-mediated inflammatory reaction in xenogeneic neonatal islet cell transplantation[J]. Transplant Direct, 2016, 2(6): e77. DOI: 10.1097/TXD.0000000000000590.
    [33]
    MOLL G, ANKRUM JA, KAMHIEH-MILZ J, et al. Intravascular mesenchymal stromal/stem cell therapy product diversification: time for new clinical guidelines[J]. Trends Mol Med, 2019, 25(2): 149-163. DOI: 10.1016/j.molmed.2018.12.006.
    [34]
    LEI J, ZHANG A, DENG H, et al. Intrapleural transplantation of allogeneic pancreatic islets achieves glycemic control in a diabetic non-human primate[J]. Am J Transplant, 2022, 22(3): 966-972. DOI: 10.1111/ajt.16875.
    [35]
    VON ZUR-MÜHLEN B, LUNDGREN T, BAYMAN L, et al. Open randomized multicenter study to evaluate safety and efficacy of low molecular weight sulfated dextran in islet transplantation[J]. Transplantation, 2019, 103(3): 630-637. DOI: 10.1097/TP.0000000000002425.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)

    Article Metrics

    Article views (267) PDF downloads(73) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return